Suraksha Diagnostic IPO (Suraksha Diagnostic Limited IPO)
Suraksha Diagnostic IPO open for bidding on 29th November 2024 and ends on 3rd December 2024.
Suraksha Diagnostic Limited, founded in 2005, is a leading provider in the diagnostic healthcare services industry, specializing in pathology and radiology. Headquartered in Kolkata, the company serves a wide network of urban and semi-urban areas, ensuring access to affordable and reliable diagnostic solutions.
The company boasts a strong focus on innovation and technology, offering state-of-the-art equipment and advanced testing methods to deliver accurate and timely reports. Its infrastructure spans multiple diagnostic centers, strategically located for comprehensive service coverage across key regions.
Suraksha Diagnostic is supported by a team of renowned healthcare professionals, enhancing its credibility and operational efficiency. It prides itself on maintaining high standards of quality and customer care, fostering trust and repeat patronage.
For more details refer to Suraksha Diagnostic IPO RHP and Suraksha Diagnostic IPO Pulse Score
Suraksha Diagnostic IPO Details
| IPO Date | 29th November 2024 to 3rd December 2024 |
| Listing Date | 6th December 2024 |
| Face Value | ₹2 per share |
| Price Band | ₹420 to ₹441 per share |
| Lot Size | 34 Shares |
| Total Issue Size | 1,91,89,330 shares (aggregating up to ₹846.25 Cr) |
| Offer for Sale | 1,91,89,330 shares of ₹2 (aggregating up to ₹846.25 Cr) |
| Issue Type | Book Built Issue IPO |
IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor | 57,56,797(30%) |
| QIB | 38,37,867(20%) |
| NII | 28,78,400(15%) |
| bNII | 19,18,934(10%) |
| sNII | 9,59,466(5%) |
| Retail | 67,16,266(35%) |
| Total | 1,91,89,330(100%) |
Suraksha Diagnostic IPO Timeline
| IPO Open | 29th November 2024 |
| IPO Close | 3rd December 2024 |
| Basis Of Allotment | 4th December 2024 |
| Initiation of Refunds | 5th December 2024 |
| Credit of Shares to Demat | 5th December 2024 |
| Listing Date | 6th December 2024 |
Fundamentals
Data as of 30th June 2024
| Market Cap | ₹2,296.76 Cr | P/E Ratio- Pre IPO | 99.31 |
| RoNW* | 4.33% | P/E Ratio- Post IPO | 73.99 |
| RoCE* | 6.32% | P/B Ratio | 13.1 |
| Debt to Equity | 0.16 | PAT Margin | 12.62% |
Note: P/E Ratio -Pre IPO is calculated based on Pre-issue Shareholding and FY Earnings of March 2024. P/E Ratio- Post IPO is calculated based on post-issue shareholding and annualized FY earnings for June 2024. RoCE and RoNW are for three-month period ended June 30, 2024
Suraksha Diagnostic IPO Objectives
The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.
Leave a Reply